| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $15.3M | +5.4% |
| Cost of Revenue | $15.0M | +8.3% |
| Gross Profit | $276K | -57.3% |
| R&D Expense | $15.2M | -36.6% |
| SG&A Expense | $43.8M | +21.3% |
| Operating Income | -$103.7M | +12.2% |
| Net Income | -$100.9M | +13.5% |
| EPS (Basic) | -$3.09 | +20.4% |
| EPS (Diluted) | -$3.09 | +20.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $36.7M | -52.7% |
| Short-term Investments | $19.1M | -60.5% |
| Accounts Receivable | $2.6M | -38.1% |
| Inventory | $1.0M | -42.9% |
| Current Assets | $61.8M | -54.6% |
| Total Assets | $121.9M | -39.7% |
| Current Liabilities | $13.4M | -14.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$77.0M | +19.2% |
| Capital Expenditures | $902K | -72.7% |
| Investing Cash Flow | $29.9M | +791.5% |
| Financing Cash Flow | $6.1M | +562.9% |
| Free Cash Flow | -$77.9M | +21.0% |
| Total Liabilities |
| $64.8M |
| -7.1% |
| Stockholders' Equity | $57.2M | -56.8% |